27 related articles for article (PubMed ID: 38663175)
1. Multicentre analysis of nucleic acid quantification using aqueous humour liquid biopsy in uveal melanoma: implications for clinical testing.
Pike SB; Reid MW; Peng CC; Chang C; Xu BY; Gombos DS; Patel S; Xu L; Berry JL
Can J Ophthalmol; 2023 Nov; ():. PubMed ID: 38036045
[TBL] [Abstract][Full Text] [Related]
2. Uveal Melanoma in Ireland.
Baily C; O'Neill V; Dunne M; Cunningham M; Gullo G; Kennedy S; Walsh PM; Deady S; Horgan N
Ocul Oncol Pathol; 2019 Apr; 5(3):195-204. PubMed ID: 31049328
[TBL] [Abstract][Full Text] [Related]
3. Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death.
Stålhammar G
Ophthalmology; 2023 Nov; ():. PubMed ID: 37995852
[TBL] [Abstract][Full Text] [Related]
4. Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70-year nationwide cohort.
Smidt-Nielsen I; Bagger M; Heegaard S; Andersen KK; Kiilgaard JF
Acta Ophthalmol; 2021 Dec; 99(8):e1474-e1482. PubMed ID: 33738986
[TBL] [Abstract][Full Text] [Related]
5. Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).
Mahendraraj K; Lau CS; Lee I; Chamberlain RS
Clin Ophthalmol; 2016; 10():2113-2119. PubMed ID: 27822007
[TBL] [Abstract][Full Text] [Related]
6. International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma.
AJCC Ophthalmic Oncology Task Force
JAMA Ophthalmol; 2015 Apr; 133(4):376-83. PubMed ID: 25555246
[TBL] [Abstract][Full Text] [Related]
7. Uveal melanoma incidence and survival analysis in Portugal between 2013 and 2022.
Geada S; Machado T; Teixeira T; Simões PC; Oliveiros B; da Luz Cachulo M; Fonseca C; Proença R
Cancer Epidemiol; 2024 Jun; 90():102575. PubMed ID: 38663175
[TBL] [Abstract][Full Text] [Related]
8. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA
Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428
[TBL] [Abstract][Full Text] [Related]
9. Uveal melanoma: trends in incidence, treatment, and survival.
Singh AD; Turell ME; Topham AK
Ophthalmology; 2011 Sep; 118(9):1881-5. PubMed ID: 21704381
[TBL] [Abstract][Full Text] [Related]
10. Uveal melanoma: relatively rare but deadly cancer.
Kaliki S; Shields CL
Eye (Lond); 2017 Feb; 31(2):241-257. PubMed ID: 27911450
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.
Lamas NJ; Martel A; Nahon-Estève S; Goffinet S; Macocco A; Bertolotto C; Lassalle S; Hofman P
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008260
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of tenascin C in peripheral blood and primary tumours at the time of uveal melanoma diagnosis.
Herrspiegel C; Plastino F; André H; Stålhammar G
Can J Ophthalmol; 2024 Jan; ():. PubMed ID: 38219791
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
